Further experimental studies have found that ERS induction, in turn, induced autophagy and apoptosis in breast cancer cell lines under the regulation of the Akt/mTOR pathway [22] and IRE1/JNK/beclin-1 [19], with the authors suggesting that ERS promotion in breast cancer may be a therapeutic target of TNBC. The gene discussed is ERN1; the disease is breast carcinoma.